56236-74-9

Basic information

• Product Name: 4-sulfamoylbenzenecarbothioamide
• CAS NO: 56236-74-9
• Molecular Formula: C₇H₈N₂O₂S₂
• Molecular Weight: 216.2806
• Mol File: 56236-74-9.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 430.9°C at 760 mmHg
• Flash Point: 214.4°C
• Density: 1.492g/cm³
• Vapor Pressure: 1.26E-07mmHg at 25°C
• Refractive Index: 1.676
• CAS DataBase Reference: 4-sulfamoylbenzenecarbothioamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-sulfamoylbenzenecarbothioamide(56236-74-9)
• EPA Substance Registry System: 4-sulfamoylbenzenecarbothioamide(56236-74-9)

Safety Data

• Hazardous Substances Data: 56236-74-9(Hazardous Substances Data)

Upstream product

• 13152-87-9 4-cyanobenzenesulfonic acid 
• 3119-02-6 4-cyanobenzenesulfonamide 

Downstream Products

• 100143-66-6 2-(4-sulfamoyl-phenyl)-thiazole-5-carboxylic acid ethyl ester 
• 101351-51-3 4-[2]furyl-2-(4-sulfamoyl-phenyl)-thiazole-5-carboxylic acid ethyl ester 
• 102009-14-3 4-cyclohexylmethyl-2-(4-sulfamoyl-phenyl)-thiazole-5-carboxylic acid ethyl ester 
• 101291-49-0 4-phenyl-2-(4-sulfamoyl-phenyl)-thiazole-5-carboxylic acid 
• 107151-73-5 4-(4-methoxy-phenyl)-2-(4-sulfamoyl-phenyl)-thiazole-5-carboxylic acid 
• 101289-61-6 4-cyclohexyl-2-(4-sulfamoyl-phenyl)-thiazole-5-carboxylic acid 
• 103151-77-5 4-cyclohexylmethyl-2-(4-sulfamoyl-phenyl)-thiazole-5-carboxylic acid 
• 100724-61-6 4-cyclopropyl-2-(4-sulfamoyl-phenyl)-thiazole-5-carboxylic acid 
• 104509-71-9 4-methoxymethyl-2-(4-sulfamoyl-phenyl)-thiazole-5-carboxylic acid 
• 110246-66-7 4-(3-isopropyl-1-methyl-cyclopentyl)-2-(4-sulfamoyl-phenyl)-thiazole-5-carboxylic acid ethyl ester 
• 102313-97-3 4-indan-5-ylmethyl-2-(4-sulfamoyl-phenyl)-thiazole-5-carboxylic acid ethyl ester 
• 101113-27-3 4-cyclopropyl-2-(4-sulfamoyl-phenyl)-thiazole-5-carboxylic acid ethyl ester 
• 101113-39-7 2-(4-sulfamoyl-phenyl)-thiazole-4,5-dicarboxylic acid diethyl ester 
• 101732-16-5 4-phenyl-2-(4-sulfamoyl-phenyl)-thiazole-5-carboxylic acid ethyl ester 

Relevant articles and documents

SUBSTITUTED THIAZOLE DERIVATIVES BEARING 3-PYRIDYL GROUPS, PROCESS FOR PREPARING THE SAME AND USE THEREOF

The present invention provides a pharmaceutical composition having a steroid C17,20-lyase inhibitory activity, which is useful as a prophylactic or therapeutic agent of prostatism, tumor such as breast cancer and the like, more particularly, a steroid C17,20-lyase inhibitor containing a compound represented by the formula: wherein A1 is an aromatic hydrocarbon group optionally having substituents or a heterocyclic group optionally having substituents, one of A2 and A3 is a hydrogen atom, a halogen atom, a C1-4 aliphatic hydrocarbon group optionally having substituents or an optionally esterified carboxyl group, the other of A2 and A3 is an aromatic hydrocarbon group optionally having substituents or a heterocyclic group optionally having substituents, and at least one of A1, A2 and A3 is a 3-pyridyl group optionally having substituents, or a salt thereof or a prodrug thereof.